Medpage Today -- Excitement here over a microbicide gel that protects women against HIV grew when researchers reported that it also protects against herpes simplex virus-2 (HSV-2) infection. In a randomized controlled trial, the vaginal gel reduced women’s risk of HIV infection by 39% compared with placebo, according to researchers.
